Skip to content
10-Q

Quarterly Report

IGC Pharma, Inc. IGC

0001185185-25-000997

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Jul 28, 2025 90.81M sh
Shares Diluted Q1 2026 · Jun 30, 2025 83.03M sh
Shares Diluted Q1 2026 · Jun 30, 2024 72.81M sh
Capex Q1 2026 · Jun 30, 2025 $8K
Capex Q1 2026 · Jun 30, 2024 $38K
Operating Cash Flow Q1 2026 · Jun 30, 2025 −$1.41M
Operating Cash Flow Q1 2026 · Jun 30, 2024 −$1.75M
Long Term Debt Q1 2026 · Jun 30, 2025 $133K
Long Term Debt Q1 2026 · Mar 31, 2025 $134K
Short Term Debt Q1 2026 · Jun 30, 2025 $3K
Short Term Debt Q1 2026 · Mar 31, 2025 $3K
Cash And Equivalents Q1 2026 · Jun 30, 2025 $454K
Cash And Equivalents Q1 2026 · Mar 31, 2025 $405K
Stockholders Equity Q1 2026 · Jun 30, 2025 $6.08M
Stockholders Equity Q1 2026 · Jun 30, 2024 $7.88M
Stockholders Equity Q1 2026 · Mar 31, 2024 $7.32M
Current Liabilities Q1 2026 · Jun 30, 2025 $1.73M
Current Liabilities Q1 2026 · Mar 31, 2025 $2.26M
Total Liabilities Q1 2026 · Jun 30, 2025 $1.87M
Total Liabilities Q1 2026 · Mar 31, 2025 $2.42M
Current Assets Q1 2026 · Jun 30, 2025 $2.15M
Current Assets Q1 2026 · Mar 31, 2025 $2.9M
Total Assets Q1 2026 · Jun 30, 2025 $7.94M
Total Assets Q1 2026 · Mar 31, 2025 $8.75M
Eps Diluted Q1 2026 · Jun 30, 2025 −$0.02
Eps Diluted Q1 2026 · Jun 30, 2024 −$0.03
Eps Basic Q1 2026 · Jun 30, 2025 −$0.02
Eps Basic Q1 2026 · Jun 30, 2024 −$0.03
Sga Expense Q1 2026 · Jun 30, 2025 $1.21M
Sga Expense Q1 2026 · Jun 30, 2024 $1.67M
Rd Expense Q1 2026 · Jun 30, 2025 $851K
Rd Expense Q1 2026 · Jun 30, 2024 $889K
Net Income Q1 2026 · Jun 30, 2025 −$1.6M
Net Income Q1 2026 · Jun 30, 2024 −$2.38M
Operating Income Q1 2026 · Jun 30, 2025 −$1.91M
Operating Income Q1 2026 · Jun 30, 2024 −$2.4M
Gross Profit Q1 2026 · Jun 30, 2025 $154K
Gross Profit Q1 2026 · Jun 30, 2024 $163K
Cost Of Revenue Q1 2026 · Jun 30, 2025 $174K
Cost Of Revenue Q1 2026 · Jun 30, 2024 $109K
Revenue Q1 2026 · Jun 30, 2025 $328K
Revenue Q1 2026 · Jun 30, 2024 $272K